132465-11-3
132465-11-3
Chemical Structure
Cinnamyl-3,4-dihydroxy-α-cyanocinnamate
Synonym(s): CDC
- CAS No.: 132465-11-3
- Formula:C19H15NO4
- Molecular Weight:321.33
IUPAC Name: cinnamyl (E)-2-cyano-3-(3,4-dihydroxyphenyl)acrylate
InChIKey: XGHYFEJMJXGPGN-UYHGDYIZSA-N
SMILES: O=C(OC/C=C/C1=CC=CC=C1)/C(C#N)=C/C2=CC=C(O)C(O)=C2
Biological Activity: Cinnamyl-3,4-dihydroxy-α-cyanocinnamate (CDC) is a potent 12/15-Lipoxygenases (LO) inhibitor. Cinnamyl-3,4-dihydroxy-α-cyanocinnamate has the potential for the research of type 1 diabetes mellitus[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Cinnamyl-3,4-dihydroxy-α-cyanocinnamate | 99.41% | Cinnamyl-3,4-dihydroxy-α-cyanocinnamate (CDC) is a potent 12/15-Lipoxygenases (LO) inhibitor. Cinnamyl-3,4-dihydroxy-α-cyanocinnamate has the potential for the research of type 1 diabetes mellitus. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Wang X, et al. 12(S)-hydroxyeicosatetraenoic acid impairs vascular endothelial permeability by altering adherens junction phosphorylation levels and affecting the binding and dissociation of its components in high glucose-induced vascular injury. J Diabetes Investig. 2019;10(3):639-649. [Content Brief]
